F
RAIL older adults are a group at high risk for morbidity and mortality (1) . Many studies have equated frailty with disability or multiple comorbidities (2-4). Fried and Walston (5) have proposed that frailty is a distinct clinical syndrome related to poorly understood underlying physiologic changes associated with aging that result in decreased strength, speed, and activity, weight loss and low energy, and as such is distinct from disability. Using data from the Cardiovascular Health Study (CHS), we developed a standardized definition for the clinical syndrome of frailty that does not depend on the presence of disability or comorbidity. Based on a consensus of clinicians, frailty was defined as a clinical syndrome or a constellation of signs and symptoms in which at least three of five possible criteria are present: (i) low strength, (ii) slow walking speed, (iii) low physical activity, (iv) self-reported unintentional weight loss, and (v) self-reported exhaustion. Thus, in this conceptualization of frailty, disease may be present either overtly or subclinically; it could play an etiologic role, although the presence of clinically apparent disease is not a necessary component of the frailty syndrome. Validation work has shown that those meeting this definition of frailty were more likely to die, be hospitalized, or become disabled over 6 years of follow-up, independent of age and other risk factors for mortality (6) .
The CHS was established to evaluate cardiovascular dis-ease (CVD) and its risk factors in older adults. At the inception of the CHS, approximately a third of the 5,201 initially enrolled subjects had clinical CVD and another third had evidence of subclinical CVD on noninvasive testing with carotid ultrasound, echocardiography, or other tests (7) . Conversely, about one third of the CHS participants had neither clinical nor subclinical CVD. The extent of subclinical disease has been shown to be a strong predictor of future clinical CVD (8) (9) (10) . In this study, we sought to characterize the relationship of the underlying extent of subclinical and clinical CVD to level of frailty, in those who were defined as frail or intermediate, compared to the nonfrail. We hypothesized that, even in those without clinically manifest CVD, the extent of underlying abnormalities in cardiovascular structure and function would be independently related to frailty status.
M ETHODS

Population
The CHS is an ongoing observational study of 5,888 adults aged 65 and older, including 5,201 recruited in 1989-90 and an additional 687 African Americans recruited in 1991-92 (11) . In the African American cohort, the baseline examination did not include some key measures. Therefore, many of the findings presented include only the original 5,201 participants, which included 217 African Americans. Those with obvious neurological disease, including those with a history of stroke, Parkinson's disease, or severe cognitive impairment (Mini-Mental State exam score Ͻ 18), and those taking Sinemet, Aricept, or antidepressants were excluded because of impaired ability to perform the measures used to define frailty status ( n ϭ 460). An additional (0.1%) were missing two or more frailty components, leaving 4,735 of the 5,201 in these analyses.
Clinical Exam
All participants underwent a baseline medical history and examination focused on CVD, including systolic (SBP) and diastolic blood pressure (DBP), ECG, ankle-arm index, carotid ultrasound, echocardiography, and pulmonary function testing (11) . At the baseline exam, participants were classified according to the presence or absence of six preexisting cardiovascular diagnoses: myocardial infarction (MI), angina, congestive heart failure (CHF), transient ischemic attack (TIA), stroke, and intermittent claudication. Those with any of these six conditions were classified as having prevalent CVD. The methods of ascertainment of these conditions have been described elsewhere (12) (13) (14) (15) .
Definition of Frailty
We have defined the syndrome of frailty as a constellation of five specific signs and symptoms, of which at least three must be present. Those with none of these criteria were considered to be nonfrail, and those with one or two criteria were considered to be an intermediate group. Conceptually, the syndrome includes domains of "shrinking," weakness, lack of energy, slowness, and sedentariness (5) . Using data available in CHS, the definition was simplified and standardized as follows:
1. Shrinking : self-reported unintentional weight loss of greater than 10 pounds in the preceding year; 2. Weakness : low strength by maximal grip strength using a Jaymar hand-held isometric dynamometer (16) based on the bottom gender-and BMI-specific quintile; 3. Lack of energy : self-reported exhaustion based on two questions from the Center for Epidemiological StudiesDepression scale [CES-D (17)]: "I felt that everything I did was an effort" and "I could not get going," with answers of "moderate amount of time" or "most of the time." 4. Slowness : slow walking speed at usual pace (16) , based on the bottom gender-and height-specific quintile. 5. Sedentariness : Low physical activity, in terms of kilocalories per week expended by self-report of physical activities in the prior 2 weeks (18), based on the bottom quintile by gender.
Noninvasive Assessment of Cardiovascular Disease
Carotid ultrasound.-To quantify the degree of thickening of the carotid artery walls, bilateral measures of intimalmedial thickening (IMT) were summarized into two variables, one for the left and right internal carotid artery and one for the left and right common carotid artery, using B-Mode Ultrasound. Plaque was described, according percent maximal stenosis for each internal carotid artery (13) .
Ankle-arm index.-The ankle-arm index (AAI) was performed to assess the degree of lower extremity arterial disease. The AAI is the ratio of the ankle to arm systolic blood pressure and is reduced to less than 0.9 when there is obstruction to blood flow in the leg (19) . For these analyses, progressive decrements in the AAI Ͻ 1.0 were categorized in 0.1 decrements: Ͼ 1.0, Ͼ 0.9-Յ 1.0, Ն 0.8-Յ 0.9, Ͻ 0.8.
Electrocardiography.-ECG abnormalities were determined by the CHS ECG Reading Center according to a standard protocol (20) . Major ECG abnormalities included ventricular conduction defects, major Q or QS abnormalities, minor Q or QS with ST-T-wave abnormalities, left ventricular (LV) hypertrophy, isolated major ST-T-wave changes, atrial fibrillation or first degree atrioventricular block (21) .
Echocardiography.-Several quantitative parameters describing cardiac size, and systolic and diastolic function were examined, including the dimensions of the LV cavity, posterior and septal walls, and left atrium, velocities in early (Epk) and late (Apk) diastole, and LV mass (22, 23) . LV fractional shortening, a quantitative measure of LV systolic function, LV combined wall thickness, and circumferential LV end-systolic wall stress were calculated as described elsewhere (24) . The qualitative global LV function was categorized by visual assessment as "normal" (corresponding to an ejection fraction (EF) of Ն 55%), as "borderline" (corresponding to EF of 45-54%), or as "abnormal" (corresponding to an EF of Ͻ 45%). Regional wall motion abnormalities were assigned coding of "normal," "mildly abnormal," "moderately abnormal," or "severely abnormal" (25, 26) .
Cerebral magnetic resonance imaging.-Cerebral magnetic resonance imaging (MRI) was performed in 1992-93 (27) . White matter disease was estimated in comparison to eight standard studies that successively increased from no changes (grade 0) to extensive confluent changes (grade 9). Infarct-like lesions (ILL) were defined as present when Ͼ 3mm (22, 28) . The sulcal prominence and ventricular size in each individual were assessed on a semiquantitative 10-point scale (grades of 0-9) (27) .
Statistical Analysis
Descriptive analyses included inspection of frequencies, histograms, and error bar plots to examine bivariate relationships of clinical and subclinical measures of CVD with frailty level. For bivariate associations, Pearson chi-square tests were used to evaluate associations between categorical variables, analysis of variance (ANOVA) F -tests for associations between continuous and categorical variables.
Because frailty was defined as a three-level categorical outcome variable, multinomial logistic regression was performed to evaluate relationships between frailty level and CVD measures. Odds ratios (ORs) were estimated for the intermediate and frail groups with respect to the nonfrail group. P values reported correspond to the null hypothesis that the ORs of interest for both groups are simultaneously equal to zero, the alternative hypothesis being that at least one OR is statistically significantly different from zero. Univariate 95% confidence intervals (CIs) are also presented for each estimate. All regressions were adjusted for age, gender, and race. Regressions involving echocardiographic measures were also adjusted for weight, height, and systolic blood pressure. Continuous variables were assessed for the linearity of their relationship with the logit function by examining the categorical codings of the variables in the regression models. Categories were determined based upon quintiles for the frail group, resulting in sufficient numbers at each frailty level to provide relatively stable OR estimates for each category. When nonlinear relationships were detected, the model was fit with piecewise linear terms. Break points for the piecewise terms (29) were determined by fitting a logistic regression (combining the frail and intermediate groups) with the adjustment covariates only. The residuals were then plotted versus the variable of interest using a scatterplot smoothing function in S-Plus and the break points chosen based on visual inspection of the plot. For these models, an additional degree of freedom was assessed in the hypothesis tests to account for the "estimation" of this additional parameter. However, due to the large number of statistical tests performed, in general, p values should not be strictly interpreted but are presented to illustrate the relative strength of association between frailty level and measures of CVD. Analyses were carried out using the SPSS for Windows, STATA (StatCorp), and S-Plus for Windows (S-PLUS) statistical packages.
R ESULTS
Of the 4,735 participants, 299 (6.3%) with Ն 3 characteristics were characterized as frail, 2,147 (45.3%) as intermediate status (1 or 2 characteristics), and the remaining 2,289 (48.3%) as not frail (Table 1) . Those deemed frail were older (mean age of 77.2 years vs 73.4 in the intermediate group vs 71.5 in the nonfrail group). A higher proportion of frail elders were women or African American. Those who were frail had less education and lower income. Education and income were strongly associated with race. All subsequent analyses were adjusted for age, gender, and race.
Clinical CVD
The prevalence of each specific cardiovascular diagnosis in each frailty group is shown in Table 2 . The proportions with a history of MI, angina, CHF, or intermittent claudication were all higher in the frail and intermediate compared to the nonfrail group. History of angioplasty, bypass surgery, and TIA was not associated with increasing frailty status. Congestive heart failure was most strongly associated with frailty status. The prevalence increased from 1.8% in the nonfrail, 4.6% in the intermediate group, to 14.0% in the frail group, with an adjusted odds ratio of 7.51 (4.66, 12.12). Those with CVD were 2.8-fold more likely to be frail than those without CVD (Table 3) . Overall, of the 1,047 with clinical CVD, 113 (11%) were frail. Conversely, 38% of the frail group had at least one of these clinical CVD diagnoses at baseline, whereas 188 (62%) did not ( Table 2) .
Blood Pressure
Systolic blood pressure was found to be associated with frailty in a nonlinear manner. Piece-wise terms were fitted for those with a SBP Ͻ 125 mm Hg, and Ն 125 mm Hg. For those with SBP Ͻ 125 mmHg, increase in SBP of 10 mm Hg was associated with about a 25% decrease in the odds of being frail. For SBP Ն 125, further increases in BP were associated with an increased odds of being frail of about 15% per 10mm Hg. SBP was not associated with intermediate frailty status. Diastolic blood pressure was also associated with frailty ( p ϭ .003), though the range was small. Pulse pressure was not associated with frailty. 
Carotid Disease
Those who were frail, as well as those who were intermediate, were more likely to have higher levels of carotid stenosis. Of the nonfrail group, 0.3% had Ͼ 75% stenosis; 0.7% of the intermediate group and 1.6% of the frail group also had Ͼ 75% stenosis (Table 4) . At higher levels of stenosis ( Ͼ 75%), the sample size, especially in the frail group, was quite small, thus the confidence intervals around the OR became quite wide (Table 5) . Nevertheless, the overall p value in this model is consistent with increasing likelihood of frailty with increasing level of stenosis. Carotid wall thicknesses were also strongly related to frailty level. Mean internal carotid IMT increased from 1.31 mm in the nonfrail to 1.42 mm in the intermediate group and 1.51 mm in the frail group. Similarly higher values for mean common carotid wall thickness were noted (Table 5 ). Figure 1 shows the age-, race-, and gender-adjusted mean maximal internal carotid wall thickness in those with and without clinical CVD and overall. The trend of increasing wall thickness with greater frailty status was more apparent in the absence of clinical CVD.
Lower Extremity Disease
The ankle-arm index was inversely related to frailty status. This relationship was found in those with or without clinical CVD in a pattern similar to that seen for the other noninvasive measures (Figure 2 ). The prevalence of progressively lower levels of AAI increased in each level of frailty. For example, in those without clinical CVD at baseline, an ankle-arm index of Ͻ0.8, consistent with severe peripheral arterial disease, was found in 2.7% of the nonfrail, 5.3% of the intermediate group, and 13.1% of the frail group (Table 4) . The OR for those with AAI Ͻ0.8 was 3.17 (95% CI ϭ 2.03, 6.24) compared to the nonfrail group, and was also significantly increased in those with an AAI of 0.8-0.9, compared to the nonfrail group, suggesting a threshold effect at an AAI Յ0.9 (Table 5) . Figure 3 illustrates that in those without clinical CVD, the prevalence of major ECG abnormalities increased with increasing frailty level. The odds of being frail versus not frail was 1.58 (95% CI ϭ 1.10, 2.26), and was 1.24 (95% CI ϭ 1.05, 1.48) for those in the intermediate group versus those who were not frail (overall p Ͻ .001, adjusted for age, race, and gender; see Table 5 ). A similar pattern was seen with ECG LV hypertrophy. The prevalence of atrial fibrillation was low in this cohort, and although it increased with each frailty level, the association was not statistically significant.
ECG Abnormalities
Echocardiographic Abnormalities
Several measures of cardiac structure and function were evaluated with respect to frailty. Figure 4 shows that mean LV mass was higher in those who are frail, after adjustment for age, gender, race, systolic blood pressure, height, and weight, than in those with and without clinical CVD. The relationship of left ventricular mass (LVM) to frailty was found to be nonlinear, and was modeled as two piecewise terms, one for LVM Ͻ140 gm and one for LVM Ն140 gm. For those with LVM Ն140, further increases in LVM were associated with increased odds of being intermediate or frail compared to the nonfrail group. The OR for a 25 gm increase in LVM was 1.10 (95% CI ϭ 1.04, 1.17) for intermediate versus nonfrail and was 1.16 (95% CI ϭ 1.03, 1.31) for the frail versus the nonfrail group.
Only some of the other echocardiographic parameters evaluated were associated with frailty level. There was no association with left atrial size, LV % fractional shortening, systolic or diastolic dimensions, systolic wall thickness, or end systolic stress (data not shown). Late peak flow velocity (mitral), but not early peak flow, was associated with frailty status. Qualitative assessment of reduced (abnormal) global wall motion (an estimate of ejection fraction) was associated with frailty status, whereas the presence of regional wall motion abnormalities (an estimate of focal ischemic damage) was not (Tables 4 and 5) .
Cerebral MRI
Several measures of vascular disease in the brain were evaluated with respect to frailty and are shown in those without clinical CVD at baseline in Tables 4 and 5 . Most striking was the association of the presence of infarct-like lesions with frailty, increasing from 22.3% in the nonfrail to 29.5% in the intermediate and 37.1% in the frail group (Table 4), overall p ϭ .005 (Table 5) . This relationship was similar in those with and without clinical CVD ( Figure 5 ). Higher white matter grade was associated with an increased risk of frailty ( Table 4 ). The white matter grade increased from 2.0 (1.3) in the nonfrail group to 2.2 (1.4) in the intermediate and 2.9 (1.8) in the frail (overall adjusted p Ͻ .003, Table 5 ). Increasing ventricular size was also associated with increased risk of frailty (overall adjusted p ϭ .003). Sulcal width score was not associated with frailty level.
CVD and Frailty: Racial Comparisons
In order to determine whether these findings were consistent across race, comparisons were made for three measures of the extent of atherosclerosis common to both cohorts that included the additional 687 African Americans. As shown previously in the CHS, both frailty and CVD were more prevalent in African Americans. Frailty status was significantly associated with lower AAI and a higher prevalence of infarct-like lesions on brain MRI in both Caucasians and African Americans (all p Ͻ .05). Common carotid wall thickness was associated with frailty status in Caucasians. A similar but nonsignificant trend was noted in the African American cohort.
DISCUSSION
We have found that frailty is associated with both clinically manifest CVD as well as the extent of cardiovascular abnormalities by noninvasive testing. Of the clinical cardiovascular conditions studied, congestive heart failure was most strongly associated with frailty status, with a sevenfold increase in prevalence in those who were most frail. While a substantial proportion (38%) of those who were frail had clinical CVD, the majority did not. This suggests that frailty is a clinical manifestation of CVD, but also suggests that many with a diagnosis of CVD function well and are not frail. In those with no history of clinical CVD, measures of the extent of CVD measured noninvasively were also associated with frailty, suggesting that subclinical, as well as clinically manifest CVD, can have a substantial impact on the health of older adults. The consistency of these findings in the African American participants suggests that their higher prevalence of CVD might explain the higher prevalence of frailty in this group. Together, these data suggest that CVD appears to be an important but not the sole contributor to frailty.
The finding of an association between clinical CVD and frailty was expected, whereas the findings of broad associations with subclinical disease markers and frailty were less predictable. We expected that excluding those with clinical disease might well have excluded those with the most extensive underlying abnormalities on noninvasive testing. In these analyses, excluding those with clinical disease attenuated some of these relationships to a degree, but did not negate them.
We hypothesize that these relationships between frailty and CVD may be explained by two different, but not mutually exclusive, pathways. The first explanation might be that the noninvasive measures of disease represent subclinical end organ damage, thus decreasing total physiologic reserve. The second possibility is that atherosclerosis, as a state of chronic inflammation, may result in a catabolic state with its systemic manifestations contributing to frailty.
It has been established that those with greater abnormalities in the arterial tree are likely to have a higher prevalence of end organ damage, particularly in the heart, brain, and kidneys. For example, CHS participants with lower extremity arterial disease are more likely to have wall motion abnormalities on echocardiography and a higher serum creatinine (30) , and those with higher carotid wall thickness are more likely to have infarct-like lesions on cerebral MRI (31) . It is possible that impairment in these important organs explains the association of these abnormalities of arterial structure and function with the clinical phenotype of frailty (5) . There may be reduced physiologic functional reserve in these organs that is not sufficient to have caused a clinical event (such as myocardial infarction or stroke), but is sufficient to cause a reduction in the ability to respond to environmental challenges, such as exercise, emotional distress, or infection. This subclinical reduction in end organ reserve is hypothesized to be part of the underlying pathophysiology that is recognized clinically as frailty (6) . Since atherosclerosis is a systemic disease, these individuals may have accumulated subclinical end organ damage in multiple vascular beds. Our data support this hypothesis, in that some of our measures that capture end organ damage, such as infarct-like lesions by MRI and major ECG abnormalities (including both ischemic changes and left ventricular hypertrophy), were associated with frailty status.
Previous work in CHS as well as in other cardiovascular cohort studies (19, 32, 33) has illustrated that there is a substantial burden of subclinical atherosclerosis in older adults. Atherosclerosis has been increasingly viewed as a disease of chronic inflammation (34) , with data linking inflammation to the development of early lesions (35) as well as with the active process of thrombosis associated with plaque rupture (36) . Studies of aging have shown that markers of chronic inflammation, such as low albumin and increased interleukin-6, are increased with age (37) and associated with incident disability (38, 39) as well as cardiovascular (40) and total mortality (41) . A person with a large degree of plaque who continues to escape a major cardiovascular event has had numerous inflammatory and thrombotic events in the vessel wall. This process may explain the association of higher levels of C-reactive protein (42) (43) (44) and fibrinogen with incident CVD (45, 46) . Thus, the ongoing healing, remodeling, and calcification associated with the accumulation of atherosclerotic plaque with age, through episodic or chronic inflammation, could contribute to the loss of lean mass and decreased appetite characteristic of chronic inflammatory states (47) and of frailty (5) . Thus, the cost of surviving acute cardiovascular events may be that a chronic inflammatory state is maintained to continue to heal these extensive lesions, with resulting loss of strength, weight loss, inactivity, and poor appetite. The data support this hypothesis in that the degree of frailty is related to the extent of atherosclerosis in all vascular beds examined.
Frailty appeared to be associated with reduced global LV function as well as increased LV mass (by ECG as well as by echocardiography), suggesting that those who are frail have relatively poorer functioning myocardium or an increase in the proportion of LV mass that is noncontractile tissue. Several of the other echocardiographic parameters associated with frailty support the idea that frailty may be associated with diastolic failure and vascular stiffness. These include the relationship of frailty with increased late peak flow and greater LV wall thickness, as well as a nonlinear or "j-shaped" relationship with systolic blood pressure. The association of frailty with clinical CHF supports the possibility that those who are frail have increased levels of inflammation, such as circulating tumor necrosis factor (48), leading to myocardial dysfunction. Future studies of frailty should directly assess markers of inflammation such as tumor necrosis factor or interleukin-6 as mediators of these relationships.
The associations of frailty status with white matter grade and infarct-like lesion on MRI also support another hypothesis of substantial clinical relevance, that those who are frail may be at risk for cognitive impairment as well. We did not include cognitive impairment in our conceptualization of frailty and excluded those who were demented at baseline from these analyses. Nevertheless, these unique data support the clinician's view that those who are frail are cognitively fragile and may be at risk for delirium and dementia (5) .
Several important limitations must be considered in examining these data. First, our definition of frailty was assessed using measures obtained at the baseline examination. Weight loss, for example, was assessed by self-report, and measures of low energy were taken from the CES-D inventory. Future work should include measured weight changes, including changes in lean mass. A more detailed measure of fatigue or lack of energy may also improve the definition of frailty. Nevertheless, in related analyses, the criteria developed appear to be valid in that those meeting these criteria for frailty were more likely to die or become disabled, even when adjusting for known risk factors (6) . Finally, the current associations are cross-sectional, and are not necessarily causal.
In summary, these findings suggest that the extent of atherosclerosis may be a precipitant of frailty in older adults. Alternatively or additionally, these noninvasive measures of CVD may reflect cumulative, subclinical end organ damage with decreased physiologic reserve that is systemically manifest as frailty. Further definition of these relationships could lead to substantially greater understanding of the consequences of cardiovascular disease in older adults as well as a basis for understanding the part of physical frailty that results from CVD.
